Status of the Keck Planet Imager and Characterizer Phase II Development

TL;DR

The paper discusses the development and testing of Phase II upgrades for the Keck Planet Imager and Characterizer, aimed at enhancing direct imaging and spectroscopy of exoplanets with new advanced modules.

Contribution

It introduces the design and laboratory testing results of the Phase II system enhancements for KPIC, including new submodules for improved performance.

Findings

Successful laboratory testing of new submodules

Enhanced system throughput and contrast expected

Preparation for deployment at Keck in early 2020

Abstract

The Keck Planet Imager and Characterizer comprises of a series of upgrades to the Keck II adaptive optics system and instrument suite to improve the direct imaging and high resolution spectroscopy capabilities of the facility instruments NIRC2 and NIRSPEC, respectively. Phase I of KPIC includes a NIR pyramid wavefront sensor and a Fiber Injection Unit (FIU) to feed NIRSPEC with a single mode fiber, which have already been installed and are currently undergoing commissioning. KPIC will enable High Dispersion Coronagraphy (HDC) of directly imaged exoplanets for the first time, providing potentially improved detection significance and spectral characterization capabilities compared to direct imaging. In favorable cases, Doppler imaging, spin measurements, and molecule mapping are also possible. This science goal drives the development of phase II of KPIC, which is scheduled to be deployed in early 2020. Phase II optimizes the system throughput and contrast using a variety of additional submodules, including a 952 element deformable mirror, phase induced amplitude apodization lenses, an atmospheric dispersion compensator, multiple coronagraphs, a Zernike wavefront sensor, and multiple science ports. A testbed is being built in the Exoplanet Technology Lab at Caltech to characterize and test the design of each of these submodules before KPIC phase II is deployed to Keck. This paper presents an overview of the design of phase II and report on results from laboratory testing.